|
|
|
|
|
|
| Industry expert Clare Grace to head efforts to build stronger relationships for better engagement with clinical research sites and patients across the globe |
Raleigh, N.C., Oct 2, 2014 - (ACN Newswire) - INC Research, a leading, global Phase I to IV contract research organization (CRO), today announced Clare Grace, PhD, has joined the Company as Vice President, Site and Patient Access. In this new global leadership role, Dr. Grace will further develop and enhance the execution of INC Research's vision to create stronger connections with high-performance clinical research sites and targeted patient populations. Dr. Grace brings nearly 20 years of strategic global clinical research leadership to the Company, including senior positions within the academic, pharmaceutical, biotech and CRO industries.
"Sites play such a critical in role in providing the real-world link between the drug development process and patients," said Alistair Macdonald, Chief Operating Officer. "INC Research understands the value sites bring to clinical research and is committed to enhancing our relationships with them to ultimately help bring new treatments to market more efficiently. We are very pleased to have Clare leading the team to execute on our vision of connecting at a deeper level with these key stakeholders and communities for mutually beneficial outcomes."
In her new role at INC Research, Dr. Grace will serve as the key advocate for sites and patients through several core focus areas, including developing strategic relationships with patient advocacy organizations and site management organizations (SMOs); implementing new and innovative approaches to work more effectively with sites; and streamlining operational functions to drive delivery, quality and efficiency.
"Establishing more meaningful relationships with clinical research sites and patients is critical to our ability to deliver new medicines to market," said Dr. Grace. "We recognize that each trial and patient have specific needs and will work tirelessly to provide a personalized approach to meet these needs."
Dr. Grace joins INC Research from PPD where she held several leadership roles, including Senior Director and Head of Global Site Intelligence, Director of Strategic Site Collaborations, and several project management positions in the oncology therapeutic area. Prior to PPD, she held clinical development roles with AstraZeneca and Antisoma. Dr. Grace holds a PhD in Molecular Oncology from the University of Manchester Institute of Science and Technology and a bachelor's degree in applied biochemistry from Liverpool John Moores University, both in England.
Dr. Grace will be among other executives from INC Research attending the Society for Clinical Research Sites' (SCRS) annual Site Solutions Summit Oct. 10-12 on Amelia Island, Fla. to further engage with sites on how to improve the clinical development process. She is scheduled to speak Oct. 11 at 4:45 p.m. on "New Technologies: How Will They Affect My Site?". INC Research is a Global Impact Partner with SCRS and a finalist for the 2014 SCRS Eagle Award recognizing outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through a strong site partnership.
To learn more about INC Research's site and patient engagement programs or to participate in current studies, please visit www.incresearch.com/how-we-work/site-relationships.
About INC Research
INC Research is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries.
Contact:
Lori Dorer, Media +1-513-345-1685
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire
Topic: Press release summary
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
